Santiago Uribe-Lewis, Jennifer Uribe, Claire Deering, Suzanne Langley, Donna Higgins, Danielle Whiting, Mohamed Metawe, Sara Khaksar, Sheel Mehta, Christos Mikropoulos, Sophie Otter, Carla Perna, Stephen Langley
OBJECTIVES: To compare survival of patients who received LDR prostate brachytherapy relative to that of peers in the general population of England, UK. PATIENTS AND METHODS: Net survival was estimated for 2472 cases treated between 2002 and 2016 using population-based analysis guidelines. Life tables adjusted for social deprivation in England from the Office for National Statistics were used to match patients by affluence based on their postcode. RESULTS: The median (range) age at time of brachytherapy was 66 (55-84) years, 84% resided in Southeast England, 51% under an index of deprivation quintile 5 (most affluent), 55% were clinical stage T1 and the remainder T2...
March 26, 2024: Brachytherapy